Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.46 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.46 |
| ▸ | PDE5A | O76074 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.39 |
| ▸ | TSHR | P16473 | 6/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | IAPP | P10997 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3418375 | 1.00 | CYSLTR2 (0.46) | CYSLTR2CYSLTR1PDE5ACYP1A2TSHR | |
| SCHEMBL4319682 | 0.93 | CYSLTR2 (0.53) | CYSLTR2CYSLTR1PDE5AOXER1SOAT2 | |
| SCHEMBL4319685 | 0.93 | CYSLTR2 (0.53) | CYSLTR2CYSLTR1PDE5AOXER1SOAT2 | |
| SCHEMBL11835698 | 0.93 | CYSLTR2 (0.53) | CYSLTR2CYSLTR1PDE5AOXER1SOAT2 | |
| SCHEMBL11835702 | 0.93 | CYSLTR2 (0.53) | CYSLTR2CYSLTR1PDE5AOXER1SOAT2 | |
| SCHEMBL3417562 | 0.89 | TLR8 (0.45) | CYSLTR2CYSLTR1PDE5ATSHRALDH1A1 | |
| SCHEMBL3417560 | 0.89 | TLR8 (0.45) | CYSLTR2CYSLTR1PDE5ATSHRALDH1A1 | |
| SCHEMBL5033527 | 0.81 | PDE5A (0.43) | CYSLTR2CYSLTR1PDE5ACYP1A2TSHR | |
| SCHEMBL6046925 | 0.80 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1PDE5ATLR8SOAT2 | |
| SCHEMBL3421085 | 0.80 | LMNA (0.33) | CYSLTR2CYSLTR1TSHRALDH1A1TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7767739-B2 | Cyanato group-containing cyclic phosphazene compound and method for producing the same | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2010-08-03 | — | — | US | disclosed |
| US-20090170983-A1 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170983-A1 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same | CENPE, CPNE4, MCM3 | CYSLTR2 1448/4885CYSLTR1 1963/4885PDE5A 2712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.